MedPath

南京正大天晴制药有限公司

Ownership
-
Established
2001-08-31
Employees
-
Market Cap
-
Website
http://www.njcttq.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

130

NMPA:130

Drug Approvals

Polyethylene Glycol 3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate and Ascorbic Acid Powder

Product Name
复方聚乙二醇(3350)电解质维C散
Approval Number
国药准字H20254017
Approval Date
Apr 30, 2025
NMPA

Ziprasidone Mesilate for Injection

Product Name
注射用甲磺酸齐拉西酮
Approval Number
国药准字H20249753
Approval Date
Dec 17, 2024
NMPA

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20249732
Approval Date
Dec 17, 2024
NMPA

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20249731
Approval Date
Dec 17, 2024
NMPA

Dapagliflozin and Metformin hydrochloride Sustained-release Tablets(III)

Product Name
达格列净二甲双胍缓释片(Ⅲ)
Approval Number
国药准字H20249467
Approval Date
Dec 1, 2024
NMPA

Dapagliflozin and Metformin hydrochloride Sustained-release Tablets(I)

Product Name
达格列净二甲双胍缓释片(Ⅰ)
Approval Number
国药准字H20249466
Approval Date
Dec 1, 2024
NMPA

Palbociclib Tablets

Product Name
哌柏西利片
Approval Number
国药准字H20249529
Approval Date
Dec 1, 2024
NMPA

Palbociclib Tablets

Product Name
哌柏西利片
Approval Number
国药准字H20249528
Approval Date
Dec 1, 2024
NMPA

Indocyanine Green for Injection

Product Name
注射用吲哚菁绿
Approval Number
国药准字H20249047
Approval Date
Oct 16, 2024
NMPA

Letermovir Injection

Product Name
来特莫韦注射液
Approval Number
国药准字H20249025
Approval Date
Oct 9, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.